Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Harmonized Manufacturing Network For Sterility Assurance Frederic Ayers at Eli Lilly and Company, Martell Winters at Nelson Labs and John Schlect at Sterigenics This presentation will provide an understanding related to Global Guidance related to holistic Contamination Control Strategies. The importance of cr... 4 months ago | 142 mins Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Dr. Jun Tian, Executive Director and Head of Upstream Process Development at WuXi Biologics Full title: Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Systems and Stringent Process and Raw Material Controls S... 4 months ago | 43 mins Annex 1 and Environmental Monitoring Program - Implementation And Justification. Benoit Ramond at Sanofi and Laurent Leblanc at bioMérieux Full Title: Annex 1 and Environmental Monitoring Program - Implementation And Justification of The Best Practices In Routine What is new? How to impl... 8 months ago | 118 mins Just in Time Release of CAR T Cell Therapies Irving Ford, Head of CAR T QC Laboratories at Celgene and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux Presented by Irving Ford, Head of CAR T QC Laboratories at Celgene The views and opinions expressed during the Webinar are those of the presenter. C... 4 years ago | 77 mins Biopharmaceutical process development – Trends/ Challenges/Opportunities Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd and Sudhakar Nagaraj, Principal Scientist, SLS at Pall Biotech Presented by Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd Current trends and regulation affecting Biopharmaceutical Industry Journey ... 3 years ago | 63 mins Biopharmaceutical process development – Trends/ Challenges/Opportunities Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd and Sudhakar Nagaraj, Principal Scientist, SLS at Pall Biotech Presented by Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd Current trends and regulation affecting Biopharmaceutical Industry Journey ... 4 years ago | 64 mins FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufa... Dr Lily Koo, Consumer Safety Officer at FDA and Dr Keen Chung, Principal Scientist (Upstream Process) at Pall Biotech FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing Presented by Dr Lily Koo, Consumer Safety Officer at Food and Dr... 4 years ago | 83 mins FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufa... Dr Lily Koo, Consumer Safety Officer at FDA and Dr Keen Chung, Principal Scientist (Upstream Process) at Pall Biotech FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing Presented by Dr Lily Koo, Consumer Safety Officer at Food and Dru... 3 years ago | 82 mins
